Both in Pharmaceuticals
Nuvectis Pharma vs Neurogene
Over the past year NVCT returned +174.3% and NGNE returned −11.8%; their daily moves had a correlation of 0.20.
NVCT +174.3% NGNE −11.8%Growth of $1, one year, split-adjusted
| Metric | NVCT | NGNE |
|---|---|---|
| Price | $18.57 | $28.82 |
| Market cap | $606.2M | $576.7M |
| Today | +1.14% | −5.26% |
| 1 month | −12.1% | +3.6% |
| 6 months | +116.9% | +10.5% |
| Year to date | +146.0% | +39.9% |
| 1 year | +188.8% | −7.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $22.2M | $225.4M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 75.8% |
| Short % of float | 11.7% | 39.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).